PL3391884T3 - Preparat do wchłaniania przezskórnego - Google Patents

Preparat do wchłaniania przezskórnego

Info

Publication number
PL3391884T3
PL3391884T3 PL16873139.6T PL16873139T PL3391884T3 PL 3391884 T3 PL3391884 T3 PL 3391884T3 PL 16873139 T PL16873139 T PL 16873139T PL 3391884 T3 PL3391884 T3 PL 3391884T3
Authority
PL
Poland
Prior art keywords
absorbable preparation
transdermally absorbable
transdermally
preparation
absorbable
Prior art date
Application number
PL16873139.6T
Other languages
English (en)
Inventor
Atsuyo HAMADA
Masaoki Goto
Original Assignee
KM Transderm Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KM Transderm Ltd. filed Critical KM Transderm Ltd.
Publication of PL3391884T3 publication Critical patent/PL3391884T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL16873139.6T 2015-12-10 2016-12-09 Preparat do wchłaniania przezskórnego PL3391884T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015257760 2015-12-10
PCT/JP2016/086819 WO2017099246A1 (ja) 2015-12-10 2016-12-09 経皮吸収製剤

Publications (1)

Publication Number Publication Date
PL3391884T3 true PL3391884T3 (pl) 2024-10-28

Family

ID=59014255

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16873139.6T PL3391884T3 (pl) 2015-12-10 2016-12-09 Preparat do wchłaniania przezskórnego

Country Status (8)

Country Link
US (1) US11786480B2 (pl)
EP (1) EP3391884B1 (pl)
JP (2) JP6894121B2 (pl)
KR (1) KR102762297B1 (pl)
CN (2) CN120960178A (pl)
ES (1) ES2981139T3 (pl)
PL (1) PL3391884T3 (pl)
WO (1) WO2017099246A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12582637B2 (en) * 2018-08-31 2026-03-24 Arctic Therapeutics Hf Topical formulation for intradermal application and uses thereof
EP3939661B1 (en) 2019-03-14 2025-09-03 Kaneka Corporation Patch
KR102218593B1 (ko) * 2020-05-13 2021-02-22 동아에스티 주식회사 안정성이 향상된 도네페질 함유 경피 흡수제제
WO2021230064A1 (ja) * 2020-05-14 2021-11-18 株式会社カネカ ブロナンセリン含有貼付剤、及びその製造方法
US20240366523A1 (en) * 2021-08-17 2024-11-07 Kaneka Corporation Patch and production method thereof
JPWO2024127805A1 (pl) * 2022-12-16 2024-06-20

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126157A (ja) * 1993-11-08 1995-05-16 Sekisui Chem Co Ltd 経皮吸収貼付剤
JPH07145047A (ja) 1993-11-25 1995-06-06 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
JPH07215850A (ja) * 1994-02-04 1995-08-15 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
JP3506165B2 (ja) 1996-01-19 2004-03-15 株式会社安川電機 ブラシレスモータ
JPH09291028A (ja) 1996-04-26 1997-11-11 Sekisui Chem Co Ltd 貼付剤
JP3699527B2 (ja) 1996-05-09 2005-09-28 積水化学工業株式会社 テープ製剤
JPH10179711A (ja) * 1996-12-24 1998-07-07 Teijin Ltd 医療用貼付材
JPH10316559A (ja) 1997-05-15 1998-12-02 Sekisui Chem Co Ltd 貼付剤
JP3358127B2 (ja) 1997-10-31 2002-12-16 花王株式会社 シート状パック及びその製造方法
JP3987655B2 (ja) * 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
KR100316559B1 (ko) 1999-11-08 2001-12-12 서명현 방향성 인쇄 조성물 및 이의 인쇄방법
JP4625157B2 (ja) 2000-04-27 2011-02-02 ニプロパッチ株式会社 インドメタシン貼付剤
JP2002212064A (ja) 2001-01-19 2002-07-31 Minoru Obara 化粧品、医薬品貼付剤用基材
KR20050037405A (ko) * 2001-10-17 2005-04-21 히사미쯔 제약 주식회사 경피 흡수형 제제
JP4799874B2 (ja) * 2005-01-25 2011-10-26 日東電工株式会社 貼付剤
JP2007119405A (ja) * 2005-10-28 2007-05-17 Sansho Kaken Kk 皮膚貼付剤
EP1985290A1 (en) 2007-04-26 2008-10-29 Sansho Cosme Inc. Skin application medicament, method of applying the same to skin and method of manufacturing the same
EP2279739B2 (en) 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezil-containing patch preparation and packaging thereof
JP5581080B2 (ja) 2009-03-19 2014-08-27 共立薬品工業株式会社 外用貼付剤
JP5404145B2 (ja) 2009-04-10 2014-01-29 日東電工株式会社 貼付剤および貼付製剤
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
CN102188363B (zh) 2010-03-09 2013-02-27 上海现代药物制剂工程研究中心有限公司 含有多奈哌齐化合物的透皮给药系统及制剂和制备方法
JP5766475B2 (ja) 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
JP6014813B2 (ja) 2010-09-03 2016-10-26 株式会社 ケイ・エム トランスダーム 経皮吸収製剤および皮膚貼付用粘着シート
JP5365964B2 (ja) 2010-12-28 2013-12-11 ニチバン株式会社 経皮吸収型鎮痛消炎貼付剤
US20140308335A1 (en) 2011-09-08 2014-10-16 KM Transderm Ltd. Transdermal preparation
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
CN104703607B (zh) * 2012-10-11 2016-11-23 久光制药株式会社 贴附剂
JP2015113339A (ja) * 2013-12-11 2015-06-22 株式会社 ケイ・エム トランスダーム 経皮吸収製剤および皮膚貼付用粘着シート
EP3040068B1 (en) 2013-06-12 2021-08-18 KM Transderm Ltd. Adhesive sheet for application to the skin, and percutaneous absorption preparation using same
JP6528154B2 (ja) 2013-09-06 2019-06-12 日東電工株式会社 ビソプロロール含有貼付製剤
KR101485822B1 (ko) * 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
EP4483902A3 (en) 2014-12-05 2025-04-16 KM Transderm Ltd. Adhesive sheet for attachment to skin and percutaneous absorption preparation using same

Also Published As

Publication number Publication date
EP3391884C0 (en) 2024-04-10
CN108778272A (zh) 2018-11-09
US20190000774A1 (en) 2019-01-03
JP2021130693A (ja) 2021-09-09
JPWO2017099246A1 (ja) 2018-10-04
ES2981139T3 (es) 2024-10-07
EP3391884A1 (en) 2018-10-24
JP7788131B2 (ja) 2025-12-18
JP6894121B2 (ja) 2021-06-23
KR102762297B1 (ko) 2025-02-03
EP3391884B1 (en) 2024-04-10
WO2017099246A1 (ja) 2017-06-15
EP3391884A4 (en) 2019-08-14
CN120960178A (zh) 2025-11-18
US11786480B2 (en) 2023-10-17
KR20180112768A (ko) 2018-10-12

Similar Documents

Publication Publication Date Title
GB201516442D0 (en) Combination therapy
IL254132A0 (en) Solid preparation
GB201502137D0 (en) Treatment
IL257976A (en) Combined treatment
GB201512365D0 (en) Novel therapy
ZA201708081B (en) Preparation comprising arabinoxylo-oligosaccharides
GB201522243D0 (en) Treatment
ZA201804155B (en) Combination therapy
GB2543540B (en) Decellularising tissue
ZA201707770B (en) Polyurethane-organopolysiloxanes
GB201504915D0 (en) Ophthalmoscope
PL3393415T3 (pl) Bandaż
EP3391884C0 (en) TRANSDERMALLY ABSORBABLE PREPARATION
PL3078787T3 (pl) Element kotwiący
GB201516068D0 (en) Novel therapy
GB201508841D0 (en) Treatment
GB201503008D0 (en) Treatment
EP3332787A4 (en) Transdermally absorbable composition
GB201505382D0 (en) Novel therapy
SG11201802551WA (en) Skin disinfectant composition
ZA201805215B (en) Preparation for nasal-nasopharyngeal treatment
GB2544323B (en) Skin barrier composition
GB201507279D0 (en) Odontalgic preparation
GB201518805D0 (en) Therapy
GB201509795D0 (en) Wound healing